Revenue
2022
Bluejay Diagnostics, Inc. (BJDX)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $249,040 | — | — |
| Gross profit | — | — | — | $48,911 | — | — |
| Research & development | $3.0M | $3.5M | $5.7M | $4.2M | $1.1M | $527,253 |
| Operating expenses | $7.0M | $7.2M | $10.3M | $9.4M | $3.2M | $1.2M |
| Operating income | −$7.0M | −$7.2M | −$10.3M | −$9.3M | −$3.2M | −$1.2M |
| EBITDAderived | — | — | — | −$9.2M | −$3.1M | −$1.0M |
| Net income | −$6.8M | −$7.7M | −$10.0M | −$9.3M | −$3.5M | −$1.2M |
| Basic EPSper diluted share | -$15.25 | -$456.75 | -$3,631.48 | -$9.22 | -$0.41 | -$0.37 |
| Diluted EPSper diluted share | -$15.25 | -$456.75 | -$3,631.48 | -$9.22 | -$0.41 | -$0.37 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 14, 2026Form 4 | Wurth Douglas ClarkDirector | BuyCommon Stock | 12.5K | $2.00 | $25.0K | 12.6K |
| Mar 14, 2026Form 4 | Dey IndranilPresident and CEO | BuyCommon Stock | 12.5K | $2.00 | $25.0K | 12.5K |
| Mar 14, 2026Form 4 | CHASE DONALD RDirector | BuyCommon Stock | 12.5K | $2.00 | $25.0K | 12.5K |
| Mar 14, 2026Form 4 | ZEIDMAN FRED SDirector | BuyCommon Stock | 12.5K | $2.00 | $25.0K | 12.5K |
| Mar 14, 2026Form 4 | Dey SvetlanaDirector | BuyCommon Stock | 12.5K | $2.00 | $25.0K | 12.5K |